Neuroendocrinology Letters, Home
Vol. 22 No. 6 Preview
Contact us
Subscription info
Neuroendocrinology Letters incl. Psychoneuroimmunology & Chronobiology

including Psychoneuroimmunology, Neuro
Reproductive Medicine, Chronobiology
and Human Ethology
ISSN 0172–780X

NEL VOL. 22 No. 6

2001; 22:402

Link to the Symposium website

First Announcement | pdf
Upcoming symposium:
2-3 May 2002, Cologne

‘Light, Endocrine Systems and Cancer’

Facts and Research Perspectives

This meeting on visible radiation and cancer will bring together some of the world’s leading experts in the pertinent research areas. As previously,* the emphasis will be on discussion of plausible biomechanisms that might explain existing experimental and epidemiological results. On this occasion the meeting will concentrate on new ideas about observed associations between light, the endocrine systems and cancer. Other specialists in related research areas will provide essential background information to stimulate further critical evaluation of the available data.

The following experts will contribute reports and comments:

DH Blask, USA
GC Brainard, USA
TC Erren, Germany
A Lerchl, Germany
S Perkowitz, USA
C Poole, USA
CJ Portier, USA
RJ Reiter, USA
KP Sauer, Germany
K Scharffetter-Kochanek, Germany
RG Stevens, USA
G Vollmer, Germany


Further information from:

Thomas Erren,
Institut und Poliklinik für Arbeits- und Sozialmedizin der Universität zu Köln,
50924 Köln (Lindenthal), Germany.
Tel: +49 221-478-5819.
Fax: +49 221-478-5119.

Preliminary program:

Session 1 Introduction
The nexus of light and cancer
Session 2 Light
Ocular and neuronal physiology
Biological rhythms
Light, hormones and aging
Session 3 Endocrine systems and cancer
Endocrine modulation and the fragile balance of homeostasis
Endocrine dismodulation and cancer
Session 4 Skin cancers
Session 5
Internal cancers

Session 6 Novel research
Session 7 Perspectives
Summary evaluation
Where are we headed?



Proceedings from the Symposium will be published in
the Neuroendocrinology Letters
(ISSN 0172-780X) in June 2002.




* Low frequency electromagnetic fields (EMF), Visible Light, Melatonin and Cancer - International symposium May 4-5, 2000; University of Cologne, Germany.

Copyright  Neuroendocrinology Letters 2001
All rights reserved. No part may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or ortherwise, without prior written permission from the Editor-in-Chief.